Neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in myelodysplastic syndromes.

In order to study if dysplastic cells are part of the abnormal chromosomal clone in myelodysplastic syndromes (MDS) we used fluorescence in situ hybridization in combination with standard May-Grünwald-Giemsa morphology (MGG/FISH) to investigate the penetration of chromosomal abnormalities into dysplastic neutrophil granulocytes in five MDS patients with documented monosomy 7 or trisomy 8 in the bone marrow at diagnosis. Neutrophil dysplasia was defined as neutrophil granulocytes with extreme hypogranulation or with nuclear abnormalities of the pelgeroid type. In one patient all dysplastic cells were derived from the abnormal chromosomal clone, while in the other four cases only 6-43% of the hypogranulated neutrophils and 33-40% of the pelgeroid granulocytes exhibited the chromosomal marker. The results suggest that neutrophil dysplasia is not a specific feature of the abnormal chromosomal clone in MDS. It is not clear, however, if the disomic dysplastic cells were derived from a parallel MDS clone with a normal karyotype, or represent residual non-clonal, normal hematopoietic cells.

[1]  G. Verhoef Clinicomorphological features of myelodysplastic syndromes , 1994 .

[2]  D. Bowen What is ineffective erythropoiesis in myelodysplastic syndromes? , 1995, Leukemia & lymphoma.

[3]  J. Bennett,et al.  Classification and morphologic features of the myelodysplastic syndromes. , 1992, Seminars in oncology.

[4]  H. Preisler,et al.  Apoptosis in bone marrow biopsy samples involving stromal and hematopoietic cells in 50 patients with myelodysplastic syndromes. , 1995, Blood.

[5]  E. Wattel,et al.  Myelodysplastic syndromes and acute myeloid leukemia with 17p deletion. An entity characterized by specific dysgranulopoïesis and a high incidence of P53 mutations. , 1995, Leukemia.

[6]  G. Tricot,et al.  The myelodysplastic syndromes: different evolution patterns based on sequential morphological and cytogenetic investigations , 1985, British journal of haematology.

[7]  Y. Kagami,et al.  Recovery of polyclonal hematopoiesis in patients with myelodysplastic syndromes following successful chemotherapy. , 1994, Leukemia.

[8]  A. Öst,et al.  Peripheral blood neutrophil morphology reflects bone marrow dysplasia in myelodysplastic syndromes , 1995, American journal of hematology.

[9]  H. Gralnick,et al.  Proposals for the classification of the myelodysplastic syndromes , 1982, British journal of haematology.

[10]  L. Kanter‐Lewensohn,et al.  Morphological changes and apoptosis in bone marrow from patients with myelodysplastic syndromes treated with granulocyte-CSF and erythropoietin. , 1997, Leukemia research.

[11]  C. Preudhomme,et al.  Combined immunophenotyping and in situ hybridization (FICTION): a rapid method to study cell lineage involvement in myelodysplastic syndromes , 1995, British journal of haematology.

[12]  S. Widell,et al.  Balloon-like platelets in myelodysplastic syndromes--a feature of dysmegakaryopoiesis? , 1987, Leukemia research.

[13]  G. Mufti,et al.  The myelodysplastic syndromes. , 1987, Springer Berlin Heidelberg.

[14]  S. Widell,et al.  Dysplastic peripheral blood polymorphs link acute myeloblastic leukaemia in elderly to the mvelodvsdastic Syndromes , 1992, European journal of haematology.

[15]  M. Ichihara,et al.  Evidence for nonclonal hematopoietic progenitor cell populations in bone marrow of patients with myelodysplastic syndromes. , 1994, Blood.

[16]  H. Heimpel,et al.  Clonal analysis of myelodysplastic syndromes: evidence of multipotent stem cell origin. , 1989, Blood.

[17]  F. Mitelman ISCN 1991 : guidelines for cancer cytogenetics : supplement to An international system for human cytogenetic nomenclature : recommendations of the Standing Committee on Human Cytogenetic Nomenclature, Subcommittee on Cancer Cytogenetics , 1992 .

[18]  A. Nordgren,et al.  Clonal cell lineage involvement in myelodysplastic syndromes studied by fluorescence in situ hybridization and morphology. , 1996, Leukemia.

[19]  A. Öst,et al.  Diagnostic significance of dysplastic features of peripheral blood polymorphs in myelodysplastic syndromes. , 1989, Leukemia research.

[20]  J. Rowley,et al.  Prognostic implications of morphology and karyotype in primary myelodysplastic syndromes , 1986 .

[21]  R. Hast,et al.  Classical morphology, esterase cytochemistry, and interphase cytogenetics of peripheral blood and bone marrow smears. , 1996, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[22]  T Hamblin,et al.  International scoring system for evaluating prognosis in myelodysplastic syndromes. , 1997, Blood.

[23]  B. Vogelstein,et al.  Differentiation of leukemia cells to polymorphonuclear leukocytes in patients with acute nonlymphocytic leukemia. , 1986, The New England journal of medicine.